| Gene symbol | CEACAM5 | Synonyms | CD66e, CEA | Type of gene | protein-coding |
| Chromosome | 19 | Map location | 19q13.2 | dbXrefs | |
| Description | CEA cell adhesion molecule 5 | ||||
| GTO ID | GTC3659 |
| Trial ID | NCT06126406 |
| Disease | Gastric Cancer | Colon Cancer | Rectal Cancer | Breast Cancer | Lung Cancer | Esophagus Cancer | Cholangiocarcinoma | Pancreas Cancer |
| Altered gene | CEA |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CEA CAR-T cells |
| Phase | Phase1 |
| Recruitment status | Recruiting |
| Title | Chimeric Antigen Receptor T Lymphocytes (CAR-T) Targeting CEA in the Treatment of CEA Positive Clinical Study of Advanced Malignant Solid Tumors |
| Year | 2023 |
| Country | China |
| Company sponsor | Chongqing Precision Biotech Co., Ltd |
| Other ID(s) | PBC055 |
| Cohort 1 | |||||||||||
|
|||||||||||